Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 4, 2007 - Issue 3
Submit an article Journal homepage
460
Views
86
CrossRef citations to date
0
Altmetric
Review

Polymeric nano- and microparticle technologies for oral gene delivery

Mayank D Bhavsar Doctoral Candidate, Northeastern University, Department of Pharmaceutical Sciences, School of Pharmacy,110 Mugar Life Sciences Building, Boston, MA 02115, USA
&
Mansoor M Amiji Professor and Associate Chair, Northeastern University, Department of Pharmaceutical Sciences, School of Pharmacy, 110 Mugar Life Sciences Building, Boston, MA 02115, USA. [email protected]
Pages 197-213 | Published online: 09 May 2007

Bibliography

  • DRUGAN A, MILLER OJ, EVANS MI: Gene therapy. Fetal Ther. (1987) 2(4):232-241.
  • GOVERDHANA S, PUNTEL M, XIONG W et al.: Regulatable gene expression systems for gene therapy applications: progress and future challenges. Mol. Ther. (2005) 12(2):189-211.
  • ULMANEN I, KALLIO A: Gene therapy of somatic cells, the principle and techniques. Ann. Clin. Res. (1986) 18(5-6):316-321.
  • ROMANO G, PACILIO C, GIORDANO A: Gene transfer technology in therapy: current applications and future goals. Stem Cells (1999) 17(4):191-202.
  • LORETZ B, FOGER F, WERLE M, BERNKOP-SCHNURCH A: Oral gene delivery: strategies to improve stability of pDNA towards intestinal digestion. J. Drug Target (2006) 14(5):311-319.
  • ROTHMAN S, TSENG H, GOLDFINE I: Oral gene therapy: a novel method for the manufacture and delivery of protein drugs. Diabetes Technol. Ther. (2005) 7(3):549-557.
  • MARTIEN R, LORETZ B, SCHNURCH AB: Oral gene delivery: design of polymeric carrier systems shielding toward intestinal enzymatic attack. Biopolymers (2006) 83(4):327-336.
  • LYSIK MA, WU-PONG S: Innovations in oligonucleotide drug delivery. J. Pharm. Sci. (2003) 92(8):1559-1573.
  • CHENG X, MING X, CROYLE MA: PEGylated adenoviruses for gene delivery to the intestinal epithelium by the oral route. Pharm. Res. (2003) 20(9):1444-1451.
  • LECOLLINET S, GAVARD F, HAVENGA MJ et al.: Improved gene delivery to intestinal mucosa by adenoviral vectors bearing subgroup B and D fibers. J. Virol. (2006) 80(6):2747-2759.
  • ROMANO G, MICHELL P, PACILIO C, GIORDANO A: Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. Stem Cells (2000) 18(1):19-39.
  • AMIJI MM (Ed.): Polymeric gene delivery: principles and applications. CRC Press, Boca Raton, FL (2005).
  • FOLDVARI M, BABIUK S, BADEA I: DNA delivery for vaccination and therapeutics through the skin. Curr. Drug Deliv. (2006) 3(1):17-28.
  • PATIL SD, RHODES DG, BURGESS DJ: DNA-based therapeutics and DNA delivery systems: a comprehensive review. AAPS J. (2005) 7(1):E61-E77.
  • LUO D, SALTZMAN WM: Synthetic DNA delivery systems. Nat. Biotechnol. (2000) 18(1):33-37.
  • PRIETO J, HERRAIZ M, SANGRO B et al.: The promise of gene therapy in gastrointestinal and liver diseases. Gut (2003) 52 (Suppl. 2):ii49-ii54.
  • DUBENSKY TW, Jr, LIU MA, ULMER JB: Delivery systems for gene-based vaccines. Mol. Med. (2000) 6(9):723-732.
  • PONCHEL G, IRACHE J: Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. (1998) 34(2-3):191-219.
  • DONNELLY JJ, WAHREN B, LIU MA: DNA vaccines: progress and challenges. J. Immunol. (2005) 175(2):633-639.
  • HORNER AA, VAN UDEN JH, ZUBELDIA JM, BROIDE D, RAZ E: DNA-based immunotherapeutics for the treatment of allergic disease. Immunol. Rev. (2001) 179:102-118.
  • JONES DH, CORRIS S, MCDONALD S, CLEGG JC, FARRAR GH: Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine (1997) 15(8):814-817.
  • ROY K, MAO HQ, HUANG SK, LEONG KW: Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. (1999) 5(4):387-391.
  • OCHIYA T, NAGAHARA S, SANO A, ITOH H, TERADA M: Biomaterials for gene delivery: atelocollagen-mediated controlled release of molecular medicines. Curr. Gene Ther. (2001) 1(1):31-52.
  • DANG JM, LEONG KW: Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. (2006) 58(4):487-499.
  • PUTNAM D: Polymers for gene delivery across length scales. Nat. Mater. (2006) 5(6):439-451.
  • KASHYAP N, MODI S, JAIN JP et al.: Polymers for advanced drug delivery. CRIPS (2004) 5(3):7-12.
  • KAI E, OCHIYA T: A method for oral DNA delivery with N-acetylated chitosan. Pharm. Res. (2004) 21(5):838-843.
  • HATTORI Y, MAITANI Y: Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer. J. Control. Release (2004) 97(1):173-183.
  • HOWARD KA, LI XW, SOMAVARAPU S et al.: Formulation of a microparticle carrier for oral polyplex-based DNA vaccines. Biochim. Biophys. Acta (2004) 1674(2):149-157.
  • KABANOV AV, FELGNER PL, SEYMOUR LW (eds.): Self-assembling complexes for gene delivery. Wiley & Sons (1998):197-218.
  • ARAL C, AKBUGA J: Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA:poly(L-lysine) complexes. J. Pharm. Pharmceut. Sci. (2003) 6(3):321-326.
  • NIE Y, ZHANG ZR, DUAN YR: Combined use of polycationic peptide and biodegradable macromolecular polymer as a novel gene delivery system: a preliminary study. Drug Deliv. (2006) 13(6):441-446.
  • HEJAZI R, AMIJI M: Chitosan-based gastrointestinal delivery systems. J. Control. Release (2003) 89(2):151-165.
  • MUMPER RJ, WANG J, CLASPELL JM, ROLLAND AP: Novel polymeric carriers for gene delivery. Proc. Intern. Symp. Control. Rel. Bioact. Mater. (1995) 22:178-179.
  • THANOU M, FLOREA BI, GELDOF M, JUNGINGER HE, BORCHARD G: Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials (2002) 23(1):153-159.
  • LEE KY, KWON IC, KIM YH, JO WH, JEONG SY: Preparation of chitosan self-aggregates as a gene delivery system. J. Control. Release (1998) 51(2-3):213-220.
  • BOZKIR A, SAKA OM: Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Deliv. (2004) 11(2):107-112.
  • BORCHARD G: Chitosans for gene delivery. Adv. Drug Deliv. Rev. (2001) 52(2):145-150.
  • BLESSING T, KURSA M, HOLZHAUSER R, KIRCHEIS R, WAGNER E: Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconjug. Chem. (2001) 12(4):529-537.
  • CARLISLE RC, BETTINGER T, OGRIS M et al.: Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors. Mol. Ther. (2001) 4(5):473-483.
  • KURSA M, WALKER GF, ROESSLER V et al.: Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug. Chem. (2003) 14(1):222-231.
  • OGRIS M, BRUNNER S, SCHULLER S, KIRCHEIS R, WAGNER E: PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. (1999) 6(4):595-605.
  • BOUSSIF O, LEZOUALC'H F, ZANTA MA et al.: A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA (1995) 92(16):7297-7301.
  • GODBEY WT, WU KK, MIKOS AG: Poly(ethylenimine) and its role in gene delivery. J. Control. Release (1999) 60(2-3):149-160.
  • PARK MR, HAN KO, HAN IK et al.: Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. J. Control. Release (2005) 105(3):367-380.
  • KATAYOSE S, KATAOKA K: Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconjug. Chem. (1997) 8(5):702-707.
  • WOLFERT MA, SCHACHT EH, TONCHEVA V et al.: Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. Hum. Gene Ther. (1996) 7(17):2123-2133.
  • FUNHOFF AM, VAN NOSTRUM CF, LOK MC et al.: Cationic polymethacrylates with covalently linked membrane destabilizing peptides as gene delivery vectors. J. Control. Release (2005) 101(1-3):233-246.
  • ARTURSSON P, ARRO E, EDMAN P, ERICSSON JL, SJOHOLM I: Biodegradable microspheres. V: stimulation of macrophages with microparticles made of various polysaccharides. J. Pharm. Sci. (1987) 76(2):127-133.
  • TABATA Y, IKADA Y: Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. J. Biomed. Mater. Res. (1988) 22(10):837-858.
  • HSU YY, HAO T, HEDLEY ML: Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres. J. Drug Target (1999) 7(4):313-323.
  • NEWMAN KD, ELAMANCHILI P, KWON GS, SAMUEL J: Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo. J. Biomed. Mater. Res. (2002) 60(3):480-486.
  • MOK H, PARK TG: PEG-assisted DNA solubilization in organic solvents for preparing cytosol specifically degradable PEG/DNA nanogels. Bioconjug. Chem. (2006) 17(6):1369-1372.
  • KAUL G, AMIJI M: Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. J. Drug Target (2004) 12(9-10):585-591.
  • KAUL G, AMIJI M: Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles. J. Pharm. Sci. (2005) 94(1):184-198.
  • KAUL G, AMIJI M: Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharm. Res. (2005) 22(6):951-961.
  • KOMMAREDDY S, AMIJI M: Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjug. Chem. (2005) 16(6):1423-1432.
  • TRUONG VL, WALSH SM, SCHWEIBERT E et al.: Gene transfer by DNA-gelatin nanospheres. Arc. Biochem. Biophys. (1999) 361:47-56.
  • TRUONG-LE VL, AUGUST JT, LEONG KW: Controlled gene delivery by DNA-gelatin nanospheres. Hum. Gene Ther. (1998) 9(12):1709-1717.
  • ZILLIES J, COESTER C: Evaluating gelatin based nanoparticles as a carrier system for double stranded oligonucleotides. J. Pharm. Pharm. Sci. (2005) 7(4):17-21.
  • TAKEUCHI H, YAMAMOTO H, KAWASHIMA Y.: Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. (2001) 47:39-54.
  • COUVREUR P: Polyalkylcyanoacrylates as colloidal drug carriers. Crit. Rev. Ther. Drug Carrier Syst. (1988) 5(1):1-20.
  • DELIE F: Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Adv. Drug Deliv. Rev. (1998) 34(2-3):221-233.
  • NARAYANI R: Oral delivery of insulin - making needles needless. Trends Biomater. Artif. Organs (2001) 15(1):12-16.
  • SAKUMA S, SUZUKI N, SUDO R et al.: Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin. Int. J. Pharm. (2002) 239(1-2):185-195.
  • FLORENCE AT: The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. (1997) 14(3):259-266.
  • QUINTANAR-GUERRERO DA, ALLEMANN E; FESSI H; DOELKER E: Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Development and Industrial Pharmacy (1998) 24(12):1113-1128.
  • SHENOY D, LITTLE S, LANGER R, AMIJI M: Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations. Mol. Pharm. (2005) 2(5):357-366.
  • SOLARO R: Nanostructured polymeric systems in targeted release of proteic drugs and in tissue engineering. China-EU Forum on Nanosized Technology. Beijng (2002).
  • GENERAL S, THUNEMANN AF: pH-sensitive nanoparticles of poly(amino acid) dodecanoate complexes. Int. J. Pharm. (2001) 230(1-2):11-24.
  • MANSOURI S, LAVIGNE P, CORSI K et al.: Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur. J. Pharm. Biopharm. (2004) 57(1):1-8.
  • JANES KA, CALVO P, ALONSO MJ: Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. (2001) 47(1):83-97.
  • THUNEMANN AF, GENERAL S: Nanoparticles of a polyelectrolyte-fatty acid complex: carriers for Q10 and triiodothyronine. J. Control. Release (2001) 75(3):237-247.
  • AKIYOSHI K, KOBAYASHI S, SHICHIBE S et al.: Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J. Control. Release (1998) 54(3):313-320.
  • DU J, ZHANG S, SUN R et al.: Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery. II. Release of albumin in vitro. J. Biomed. Mater. Res. B Appl Biomater (2005) 72(2):299-304.
  • GENERAL S, RUDLOFF J, THUNEMANN AF: Hollow nanoparticles via stepwise complexation and selective decomplexation of poly(ethylene imine). Chem Commun (Camb) (2002) 5:534-535.
  • SANG YOO H, GWAN PARK T: Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin. J. Pharm. Sci. (2004) 93(2):488-495.
  • SUN YP, MEZIANI MJ, PATHAK P, QU L: Polymeric nanoparticles from rapid expansion of supercritical fluid solution. Chemistry (2005) 11(5):1366-1373.
  • YOUNG TJ, JOHNSON KP, PACE GW, MISHRA AK: Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution. AAPS PharmSciTech. (2004) 5(1):E11.
  • KERNELL AM, RINGERTZ NR: Cytochemical characterization of deoxyribonucleoprotein by UV-microspectrophotometry on heat denatured cell nuclei. Exp Cell Res (1972) 72(1):240-251.
  • LUNAU M, LEMKE A, WALTHER K, MARTENS-HABBENA W, SIMON M: An improved method for counting bacteria from sediments and turbid environments by epifluorescence microscopy. Environ Microbiol (2005) 7(7):961-968.
  • VALLE O, LIEN T, KNUTSEN G: Fluorometric determination of DNA and RNA in Chlamydomonas using ethidium bromide. J. Biochem. Biophys. Methods (1981) 4(5-6):271-277.
  • TEARE JM, ISLAM R, FLANAGAN R et al.: Measurement of nucleic acid concentrations using the DyNA Quant and the GeneQuant. Biotechniques (1997) 22(6):1170-1174.
  • HU FQ, YUAN H, ZHANG HH, FANG M: Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int. J. Pharm. (2002) 239(1-2):121-128.
  • VAN DER LUBBEN IM, KERSTEN G, FRETZ MM et al.: Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine (2003) 21(13-14):1400-1408.
  • VAN DER LUBBEN IM, VERHOEF JC, VAN AELST AC, BORCHARD G, JUNGINGER HE: Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer's patches. Biomaterials (2001) 22(7):687-694.
  • LI JK, WANG N, WU XS: A novel biodegradable system based on gelatin nanoparticles and poly(lactic-co-glycolic acid) microspheres for protein and peptide drug delivery. J. Pharm. Sci. (1997) 86(8):891-895.
  • MAKRAUER FL, BURAKOFF R: Biologic and novel therapy of the inflammatory bowel diseases. Curr Med Chem -Anti-Inflammatory and Anti-Allergy Agents (2005) 4:319-331.
  • ARDIZZONE S, BIANCHI PORRO G: Inflammatory bowel disease: new insights into pathogenesis and treatment. J. Intern. Med. (2002) 252(6):475-496.
  • PODOLSKY DK: Inflammatory bowel disease. N. Engl. J. Med. (2002) 347(6):417-429.
  • KORZENIK JR, PODOLSKY DK: Evolving knowledge and therapy of inflammatory bowel disease. Nat. Rev. Drug Discov. (2006) 5(3):197-209.
  • CHEN J, YANG WL, LI G et al.: Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles. World J. Gastroenterol. (2004) 10(1):112-116.
  • HAAS J, RAVI KUMAR MN, BORCHARD G, BAKOWSKY U, LEHR CM: Preparation and characterization of chitosan and trimethyl-chitosan-modified poly-(epsilon-caprolactone) nanoparticles as DNA carriers. AAPS PharmSciTech. (2005) 6(1):E22-E30.
  • PRABHA S, ZHOU WZ, PANYAM J, LABHASETWAR V: Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm. (2002) 244(1-2):105-115.
  • TINSLEY-BOWN AM, FRETWELL R, DOWSETT AB, DAVIS SL, FARRAR GH: Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. J. Control. Release (2000) 66(2-3):229-241.
  • O'HAGAN D T, SINGH M, ULMER JB: Microparticle-based technologies for vaccines. Methods (2006) 40(1):10-19.
  • COHEN J: Naked DNA points way to vaccines. Science (1993) 259(5102):1691-1692.
  • FU TM, FRIEDMAN A, ULMER JB, LIU MA, DONNELLY JJ: Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. J. Virol. (1997) 71(4):2715-2721.
  • ULMER JB, DECK RR, DEWITT CM et al.: Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine (1994) 12(16):1541-1544.
  • CHEN SC, JONES DH, FYNAN EF et al.: Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. (1998) 72:5757-5761.
  • HERRMANN JE, CHEN SC, JONES DH et al.: Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles. Virology (1999) 259(1):148-153.
  • KANEKO H, BEDNAREK I, WIERZBICKI A et al.: Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein. Virology (2000) 267(1):8-16.
  • MITTAL SK, AGGARWAL N, SAILAJA G et al.: Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response. Vaccine (2000) 19(2-3):253-263.
  • HE XW, WANG F, JIANG L et al.: Induction of mucosal and systemic immune response by single-dose oral immunization with biodegradable microparticles containing DNA encoding HBsAg. J. Gen. Virol. (2005) 86(Pt 3):601-610.

Patents

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.